[go: up one dir, main page]

AR220567A1 - Procedimiento para la preparacion de derivados de 3-((2,4-disustituido)-fenil)-piperidina - Google Patents

Procedimiento para la preparacion de derivados de 3-((2,4-disustituido)-fenil)-piperidina

Info

Publication number
AR220567A1
AR220567A1 AR277236A AR27723679A AR220567A1 AR 220567 A1 AR220567 A1 AR 220567A1 AR 277236 A AR277236 A AR 277236A AR 27723679 A AR27723679 A AR 27723679A AR 220567 A1 AR220567 A1 AR 220567A1
Authority
AR
Argentina
Prior art keywords
disstituted
piperidine
phenyl
derivatives
procedure
Prior art date
Application number
AR277236A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR220567A1 publication Critical patent/AR220567A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/48Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epoxy Compounds (AREA)
AR277236A 1977-09-13 1979-07-10 Procedimiento para la preparacion de derivados de 3-((2,4-disustituido)-fenil)-piperidina AR220567A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/832,869 US4147872A (en) 1977-09-13 1977-09-13 3-[2-Hydroxy-4-(substituted)-phenyl]azacycloalkanes and derivatives thereof as analgesic agents and intermediates therefor

Publications (1)

Publication Number Publication Date
AR220567A1 true AR220567A1 (es) 1980-11-14

Family

ID=25262819

Family Applications (2)

Application Number Title Priority Date Filing Date
AR273692A AR222019A1 (es) 1977-09-13 1978-09-13 Procedimiento para la preparacion de derivados de 3-(2-hidroxi-4-fenilo(sustituido))-3-hidroxi piperidina o-1,2,5,6-tetrahidropiridina
AR277236A AR220567A1 (es) 1977-09-13 1979-07-10 Procedimiento para la preparacion de derivados de 3-((2,4-disustituido)-fenil)-piperidina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AR273692A AR222019A1 (es) 1977-09-13 1978-09-13 Procedimiento para la preparacion de derivados de 3-(2-hidroxi-4-fenilo(sustituido))-3-hidroxi piperidina o-1,2,5,6-tetrahidropiridina

Country Status (23)

Country Link
US (1) US4147872A (es)
JP (5) JPS5935397B2 (es)
AR (2) AR222019A1 (es)
AT (1) AT368753B (es)
AU (1) AU507953B1 (es)
BE (1) BE870403A (es)
CA (1) CA1113463A (es)
CH (1) CH638187A5 (es)
DE (1) DE2839883A1 (es)
DK (1) DK401078A (es)
ES (2) ES473287A1 (es)
FI (1) FI66173C (es)
FR (4) FR2401913A1 (es)
GB (1) GB2004548B (es)
IE (1) IE47717B1 (es)
IL (1) IL55555A (es)
IT (1) IT1099026B (es)
LU (1) LU80219A1 (es)
NL (1) NL7809272A (es)
PH (1) PH15372A (es)
PT (1) PT68542A (es)
SE (2) SE7809606L (es)
YU (1) YU215678A (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241071A (en) * 1977-01-27 1980-12-23 American Hoechst Corporation Antidepressant (α-phenyl-2-tolyl)azacycloalkanes
FI792076A7 (fi) * 1978-07-05 1981-01-01 Ciba Geigy Ag Menetelmä uusien fenyylipiperidiinijohdannaisten valmistamiseksi.
US4216218A (en) * 1979-02-23 1980-08-05 American Hoechst Corporation Antidepressant and analgesic 4-aryloxy- and 4-arylthio-3-phenylpiperidines
US4312876A (en) * 1979-02-23 1982-01-26 Hoechst-Roussel Pharmaceuticals Incorporated Antidepressive and analgesic 4-aryloxy- and 4-arylthio-3-phenylpiperidines
US4302590A (en) * 1979-02-23 1981-11-24 Hoechst-Roussel Pharmaceuticals, Inc. Intermediates for the preparation of 4-aryloxy-3-phenylpiperidines
ZA821888B (en) * 1981-04-01 1983-02-23 Haessle Ab Novel phenyl-piperidines
US4709016A (en) * 1982-02-01 1987-11-24 Northeastern University Molecular analytical release tags and their use in chemical analysis
US4529732A (en) * 1983-03-14 1985-07-16 Pfizer Inc. 2-[2-Hydroxy-4-(substituted)phenyl]piperidines
FI864570A0 (fi) * 1986-11-11 1986-11-11 Farmos Oy Terapeutiskt anvaendbar foerening.
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CA2495903A1 (en) * 2002-08-23 2004-03-04 University Of Connecticut Novel biphenyl and biphenyl-like cannabinoids
DE102004036349A1 (de) * 2004-07-27 2006-03-23 Grünenthal GmbH Substituierte 3-Phenylpiperidin-Derivate
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
HUE059078T2 (hu) 2009-02-20 2022-10-28 Enhanx Biopharm Inc Glutation-alapú hatóanyagszállító rendszer
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
BR112015019208A2 (pt) * 2013-02-14 2017-07-18 Galderma Res & Dev processo de síntese

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2310761A1 (fr) * 1975-05-16 1976-12-10 Roussel Uclaf Nouveaux derives de la phenyl-piperidine et leurs sels, procede de preparation et application a titre de medicaments

Also Published As

Publication number Publication date
JPS5463086A (en) 1979-05-21
DK401078A (da) 1979-03-14
SE7809606L (sv) 1979-03-14
CH638187A5 (fr) 1983-09-15
PH15372A (en) 1982-12-10
GB2004548A (en) 1979-04-04
JPS5935397B2 (ja) 1984-08-28
ES473287A1 (es) 1980-03-01
FR2412531B1 (es) 1983-01-14
FR2401913B1 (es) 1983-01-21
JPS5538366A (en) 1980-03-17
FI782793A7 (fi) 1979-03-14
JPS5538365A (en) 1980-03-17
US4147872A (en) 1979-04-03
FR2412530B1 (es) 1982-11-12
YU215678A (en) 1983-06-30
FR2412529A1 (fr) 1979-07-20
FR2412530A1 (fr) 1979-07-20
CA1113463A (en) 1981-12-01
JPS5492973A (en) 1979-07-23
FR2401913A1 (fr) 1979-03-30
BE870403A (fr) 1979-03-12
PT68542A (en) 1978-10-01
DE2839883A1 (de) 1979-03-15
JPS5495577A (en) 1979-07-28
SE8305422D0 (sv) 1983-10-03
IT1099026B (it) 1985-09-18
JPS5640155B2 (es) 1981-09-18
FI66173C (fi) 1984-09-10
NL7809272A (nl) 1979-03-15
SE8305422L (sv) 1983-10-03
IL55555A0 (en) 1978-12-17
IE781837L (en) 1979-03-13
IE47717B1 (en) 1984-05-30
ES480151A1 (es) 1980-04-01
IT7827557A0 (it) 1978-09-12
FR2412529B1 (es) 1983-01-14
GB2004548B (en) 1982-03-24
FI66173B (fi) 1984-05-31
AT368753B (de) 1982-11-10
AR222019A1 (es) 1981-04-15
AU507953B1 (en) 1980-03-06
IL55555A (en) 1982-08-31
LU80219A1 (fr) 1980-04-21
FR2412531A1 (fr) 1979-07-20
ATA658078A (de) 1982-03-15

Similar Documents

Publication Publication Date Title
AR219560A1 (es) Procedimiento para la preparacion de derivados de 5,5-dimetil-hidantoina
AR227015A1 (es) Un procedimiento para la preparacion de derivados de 3-(i-imidazolilmetil)-indol
AR220567A1 (es) Procedimiento para la preparacion de derivados de 3-((2,4-disustituido)-fenil)-piperidina
AR221851A1 (es) Procedimiento para la preparacion de derivados de 4-piperidino-6,7-dialcoxi-quinazolina
MX5306E (es) Procedimiento mejorado para la preparacion de 3-(2-hidroxi-4-(substituido)fenil)cicloalcanol
AR213555A1 (es) Procedimiento para la preparacion de 2,5-diclorofenol
AR216937A1 (es) Procedimiento para la preparacion de 1,1,1,2-tetrafluoretano
AR228011A1 (es) Procedimiento para la preparacion de derivados sustituidos de 2,5,5,8a-tetrametil-1,2,3,4,4a,5,6,7,8,8a-decahidronaftaleno-1-spiro-2'-(4',6',7'-sustituido-2',3'-dihidrobenzofurano)
AR224110A1 (es) Procedimiento para la preparacion de derivados de 5(6)-benzimidazoles
RO77485A (ro) Procedeu pentru prepararea 1,2,3-tiadiazol-3-in-5-ilidenureelor
MX5256E (es) Procedimiento para la preparacion de derivados de 20,21-dinoreburnamenina
AR225276A1 (es) Procedimiento para la preparacion de 1,1,1,2-tetrafluoroetano
AR218498A1 (es) Procedimiento de preparacion de derivados de 1,3-difenoxipropan-2-ona
AR217688A1 (es) Procedimiento para la preparacion de derivados de trans-2-sustituido-5-aril-2,3,4,4a,5,9b-hexahidro-1h-pirido(4,3-b)-indol
ES497530A0 (es) Procedimiento para la preparacion de derivados de 2,3-indo- lediona
ES493931A0 (es) Procedimiento de preparacion de nuevos derivados de la 3,4,5-trimetoxi-cinamoil-piperazina
SE7804878L (sv) Forfarande for framstellning av 1,2-dikloretan
MX6009E (es) Procedimiento para la preparacion de tetrahidro-1,3,5-tiadiazin-4-onas
MX5933E (es) Procedimiento para la preparacion de 4,5-diciclo-2-(tiosubstituidos)-imidazoles
ES501213A0 (es) Procedimiento para la preparacion de derivados de 2,3,4,5- tetrahidro-1-benzoxepin-3,5-diona
AR230835A1 (es) Procedimiento para la obtencion de derivados de 2,1,3-tiadiazin-4-ona-2,2-dioxido
ES494286A0 (es) Procedimiento de preparacion de nuevos derivados 1,1,2-tri- fenilpropanos y -propenos
IT1094983B (it) Procedimento per la preparazione di 3,5 di alogeno-aniline
MX6120E (es) Procedimiento mejorado para preparar derivados de 1-(3-(3,4,5-trimetoxifenoxi)-2-hidroxipropil)-4-aril-piperazina
AR217335A1 (es) Procedimiento para preparar derivados de la 2,6-difenil-3,7-dioxabiciclo-(3,3,0)-octano-4,8-diona